Wen Wee Ma Selected Research

Lab-On-A-Chip Devices

11/2023	Microfluidic Organoid Cultures Derived from Pancreatic Cancer Biopsies for Personalized Testing of Chemotherapy and Immunotherapy.
1/2023	Patient-Specific Microfluidic Cancer Spheroid Cultures for Testing Cancer Therapies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wen Wee Ma Research Topics

Disease

41	Neoplasms (Cancer) 04/2024 - 09/2008
22	Pancreatic Neoplasms (Pancreatic Cancer) 02/2024 - 12/2010
15	Adenocarcinoma 02/2024 - 12/2010
5	Colorectal Neoplasms (Colorectal Cancer) 04/2024 - 01/2013
5	Fatigue 04/2024 - 12/2010
4	Hepatocellular Carcinoma (Hepatoma) 04/2024 - 02/2015
4	Disease Progression 01/2022 - 10/2013
4	Neutropenia 10/2013 - 09/2008
3	Exanthema (Rash) 09/2017 - 08/2013
3	Diarrhea 01/2017 - 08/2013
3	Nausea 01/2017 - 08/2013
2	Cholangiocarcinoma 02/2024 - 01/2022
2	Biliary Tract Neoplasms (Biliary Tract Cancer) 01/2021 - 01/2019
2	Mucositis 01/2017 - 09/2008
2	Vomiting 01/2017 - 10/2016
2	Melanoma (Melanoma, Malignant) 10/2016 - 02/2015
1	Embolism (Embolus) 04/2024
1	Dehydration (Water Stress) 04/2024
1	Asthenia 04/2024
1	Liver Neoplasms (Liver Cancer) 02/2024
1	Neoplasm Metastasis (Metastasis) 02/2024
1	Hematologic Neoplasms (Hematological Malignancy) 11/2023
1	Microsatellite Instability 01/2023
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 11/2022
1	Thrombocytopenia 3 01/2022
1	Body Weight (Weight, Body) 01/2022
1	Glioma (Gliomas) 01/2022
1	Glioblastoma (Glioblastoma Multiforme) 01/2022
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2020
1	Pathologic Complete Response 12/2017
1	Rectal Neoplasms (Rectal Cancer) 12/2017
1	Turcot syndrome 05/2017

Drug/Important Bio-Agent (IBA)

13	Gemcitabine FDA Link 04/2024 - 04/2012
6	Capecitabine (Xeloda)FDA Link 04/2024 - 12/2010
5	Biomarkers (Surrogate Marker)IBA 04/2024 - 08/2013
5	Paclitaxel (Taxol)FDA LinkGeneric 02/2024 - 10/2013
4	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2024 - 01/2021
3	Proteins (Proteins, Gene)FDA Link 05/2023 - 09/2011
3	Immune Checkpoint InhibitorsIBA 01/2023 - 05/2017
3	Irinotecan (Camptosar)FDA LinkGeneric 01/2022 - 01/2013
3	Erlotinib Hydrochloride (CP 358,774)FDA Link 09/2017 - 12/2010
3	EnzymesIBA 01/2017 - 12/2010
3	130-nm albumin-bound paclitaxelIBA 07/2016 - 10/2013
2	Tyrosine Kinase InhibitorsIBA 04/2024 - 08/2013
2	Circulating Tumor DNAIBA 02/2024 - 10/2023
2	Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA 02/2024 - 11/2023
2	AntibodiesIBA 05/2023 - 11/2019
2	pembrolizumabIBA 01/2023 - 01/2022
2	Cetuximab (Erbitux)FDA Link 11/2019 - 01/2013
2	sonidegibIBA 11/2019 - 01/2019
2	Fluorouracil (Carac)FDA LinkGeneric 01/2017 - 04/2015
2	Sorafenib (BAY 43-9006)FDA Link 02/2015 - 02/2015
2	pazopanib FDA Link 08/2013 - 08/2013
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 04/2024
1	nintedanibIBA 04/2024
1	Bevacizumab (Avastin)FDA Link 04/2024
1	ribociclibIBA 04/2024
1	Glycogen Synthase (Synthase I)IBA 11/2023
1	Chimeric Antigen ReceptorsIBA 05/2023
1	Monoclonal AntibodiesIBA 05/2023
1	EpitopesIBA 05/2023
1	AntigensIBA 05/2023
1	blinatumomabIBA 05/2023
1	matrigelIBA 01/2023
1	Culture MediaIBA 11/2022
1	methanesulfonic acid (methanesulfonate)IBA 01/2022
1	Lomustine (CCNU)FDA Link 01/2022
1	Dosage Forms (Dosage Form)IBA 01/2022
1	N-acetyltalosaminuronic acid (NAT)IBA 01/2022
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2022
1	JNK Mitogen-Activated Protein KinasesIBA 12/2021
1	ceritinibIBA 12/2021
1	Anaplastic Lymphoma KinaseIBA 12/2021
1	Proto-Oncogene Proteins c-metIBA 12/2021
1	BilirubinIBA 01/2021
1	Carboplatin (JM8)FDA LinkGeneric 01/2021
1	Peptide Receptors (Peptide Receptor)IBA 01/2020
1	Radioisotopes (Radionuclides)IBA 01/2020
1	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2020
1	Drug CombinationsIBA 11/2019
1	Growth Factor ReceptorsIBA 11/2019
1	4- amino- 5- fluoro- 3- (5- (4- methylpiperazin- 1- yl)- 1H- benzimidazol- 2- yl)quinolin- 2(1H)- oneIBA 01/2019
1	Smoothened ReceptorIBA 01/2019
1	LigandsIBA 01/2019
1	HhAntag691IBA 01/2019
1	4- imino- 1,3- diazabicyclo(3.1.0)hexan- 2- oneIBA 01/2018
1	CotinineIBA 09/2017
1	Nicotine FDA Link 09/2017

Therapy/Procedure

23	Therapeutics 11/2023 - 09/2011
16	Drug Therapy (Chemotherapy) 02/2024 - 08/2015
6	Neoadjuvant Therapy 03/2022 - 12/2017
4	Immunotherapy 11/2023 - 08/2015
2	Lab-On-A-Chip Devices 11/2023 - 01/2023
2	Combination Drug Therapy (Combination Chemotherapy) 01/2020 - 06/2012
1	Liver Transplantation 02/2024
1	Cell- and Tissue-Based Therapy (Cell Therapy) 05/2023
1	Precision Medicine 11/2022
1	Oral Administration 01/2022
1	Immunomodulation 01/2022
1	Adjuvant Chemotherapy 12/2017